These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2140987)

  • 21. A Three Month Home Exercise Programme Augmented with Nordic Poles for Patients with Intermittent Claudication Enhances Quality of Life and Continues to Improve Walking Distance and Compliance After One Year.
    Oakley C; Spafford C; Beard JD
    Eur J Vasc Endovasc Surg; 2017 May; 53(5):704-709. PubMed ID: 28365377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does percutaneous transluminal angioplasty improve quality of life?
    Keeling AN; Naughton PA; O'Connell A; Lee MJ
    J Vasc Interv Radiol; 2008 Feb; 19(2 Pt 1):169-76. PubMed ID: 18341944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study.
    Nylaende M; Kroese AJ; Morken B; Stranden E; Sandbaek G; Lindahl AK; Arnesen H; Seljeflot I
    Vasc Med; 2007 Nov; 12(4):275-83. PubMed ID: 18048463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous angioplasty of the superior gluteal artery for buttock claudication: a report of seven cases and literature review.
    Batt M; Baque J; Bouillanne PJ; Hassen-Khodja R; Haudebourg P; Thevenin B
    J Vasc Surg; 2006 May; 43(5):987-91. PubMed ID: 16678694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SUPERvised exercise therapy or immediate PTA for intermittent claudication in patients with an iliac artery obstruction--a multicentre randomised controlled trial; SUPER study design and rationale.
    Frans FA; Bipat S; Reekers JA; Legemate DA; Koelemay MJ;
    Eur J Vasc Endovasc Surg; 2012 Apr; 43(4):466-71. PubMed ID: 22326696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The haemodynamic effects of percutaneous transluminal angioplasty.
    Lamerton AJ; Nicolaides AN; Sutton D; Eastcott HH
    Int Angiol; 1985; 4(1):93-7. PubMed ID: 2936853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study.
    Cejna M; Thurnher S; Illiasch H; Horvath W; Waldenberger P; Hornik K; Lammer J
    J Vasc Interv Radiol; 2001 Jan; 12(1):23-31. PubMed ID: 11200349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the limb swell after revascularisation by percutaneous transluminal angioplasty?
    Payne SP; Jones K; Painter D; Galland RB; Collin J
    Eur J Vasc Endovasc Surg; 1995 Apr; 9(3):272-6. PubMed ID: 7620952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease.
    Kalbaugh CA; Taylor SM; Blackhurst DW; Dellinger MB; Trent EA; Youkey JR
    J Vasc Surg; 2006 Aug; 44(2):296-302; discussion 302-3. PubMed ID: 16814976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nature and importance of changes in toe-brachial pressure indices following percutaneous transluminal angioplasty for leg ischaemia.
    Ray SA; Buckenham TM; Belli AM; Taylor RS; Dormandy JA
    Eur J Vasc Endovasc Surg; 1997 Aug; 14(2):125-33. PubMed ID: 9314855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease.
    Mazari FA; Khan JA; Carradice D; Samuel N; Gohil R; McCollum PT; Chetter IC
    Br J Surg; 2013 Aug; 100(9):1172-9. PubMed ID: 23842831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twelve-months follow-up of supervised exercise after percutaneous transluminal angioplasty for intermittent claudication: a randomised clinical trial.
    Bø E; Hisdal J; Cvancarova M; Stranden E; Jørgensen JJ; Sandbæk G; Grøtta OJ; Bergland A
    Int J Environ Res Public Health; 2013 Nov; 10(11):5998-6014. PubMed ID: 24284358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group.
    Tetteroo E; van der Graaf Y; Bosch JL; van Engelen AD; Hunink MG; Eikelboom BC; Mali WP
    Lancet; 1998 Apr; 351(9110):1153-9. PubMed ID: 9643685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the results of percutaneous transluminal angioplasty and stenting with medical treatment for claudicants who have superficial femoral artery occlusive disease.
    Wilson S; Gelfand D; Jimenez J; Gordon I
    Vascular; 2006; 14(2):81-7. PubMed ID: 16956476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial.
    Saxon RR; Coffman JM; Gooding JM; Natuzzi E; Ponec DJ
    J Vasc Interv Radiol; 2003 Mar; 14(3):303-11. PubMed ID: 12631634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease.
    Treesak C; Kasemsup V; Treat-Jacobson D; Nyman JA; Hirsch AT
    Vasc Med; 2004 Nov; 9(4):279-85. PubMed ID: 15678620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
    Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of percutaneous transluminal angioplasty on transcutaneous oxygen pressure in patients with peripheral arterial occlusive disease.
    Wagner HJ; Schmitz R; Alfke H; Klose KJ
    Radiology; 2003 Mar; 226(3):791-7. PubMed ID: 12601207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of endovascular intervention on pain and sensory thresholds in nondiabetic patients with intermittent claudication: a pilot study.
    Lang PM; Vock G; Schober GM; Kramer S; Abahji T; Crispin A; Irnich D; Hoffmann U
    J Pain; 2009 Mar; 10(3):264-73. PubMed ID: 19010739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
    Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
    Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.